Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature

By HospiMedica International staff writers
Posted on 08 Oct 2026

Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. More...

Recombinant growth hormone therapy can support growth in these patients, but responses differ widely. This variability makes it difficult for clinicians and families to anticipate benefit and set realistic expectations. To help address this challenge, researchers have developed a predictive model for individualized growth hormone response.

Researchers at Chungnam National University investigated height percentile changes over time in children with ISS who received growth hormone treatment. The model uses age- and sex-adjusted height percentiles instead of height gain in centimeters alone. This method was designed to show catch-up growth relative to peers of the same age and sex. The study was made available online in Value in Health on July 21, 2026.

The retrospective, single-center study analyzed 91 prepubertal Korean children with ISS, including 41 boys and 50 girls. All children received recombinant human growth hormone, or somatropin, between July 2020 and December 2023. Treatment was given subcutaneously six to seven times per week, and doses were adjusted during routine care. Researchers used demographic, growth, parental height, laboratory, and treatment data from medical records.

Cumulative growth hormone exposure was incorporated into a Gompertz nonlinear mixed-effects model to characterize growth trajectories and individual response differences. Over a mean treatment period of 619 ± 307 days, mean height percentile increased from 1.26 at baseline to 9.16 at follow-up. The model estimated a total growth-response parameter of about 17.2 percentile points, although responses varied substantially among patients. Two-year simulations showed median predicted height percentiles ranging from 4.0% in lower-response profiles to 31.0% in higher-response profiles.

The team also developed GrowCast, a web-based tool that generates individualized predicted height and percentile trajectories. The tool uses age, sex, height, weight, paternal height, insulin-like growth factor-binding protein 3 level, and growth hormone dose. The platform may support treatment planning and clinician-family discussions, but it is not yet a validated dosing-prescription tool. Larger prospective, multicenter studies are needed before routine clinical implementation.

“Three baseline characteristics were associated with a greater predicted response: higher body mass index (BMI), lower insulin-like growth factor-binding protein 3 (IGFBP-3) levels, and shorter paternal height, with BMI showing the strongest association,” said Professor Jung-woo Chae, who led the research. “GrowCast enables clinicians to compare modeled treatment scenarios and communicate potential growth trajectories with patients and families.”

Related Links
Chungnam National University 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hybrid Arch Device
Neo EDE
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.